Literature DB >> 9743939

[Topical administration of metronidazole gel as an effective therapy alternative in chronic Demodex blepharitis--a case report].

A K Junk1, A Lukacs, A Kampik.   

Abstract

BACKGROUND: Blepharoconjunctivitis is the commonest manifestation of ocular rosacea. Cilia epilation proves Demodex folliculorum, considered an etiologic factor in rosacea. Complications and differential diagnosis include dry eyes, seborrheic, bacterial and allergic blepharoconjunctivitis. Treatment involves lid scrubs and mercury ointment, its duration is limited to 6 weeks under frequent control due to corneal toxicity of mercury. HISTORY AND SIGNS: 30-year-old female with complaint of red, irritated eyes for 21 years, resistant to antibiotics and antiallergics. General medical history unremarkable, mercury allergy. Acuity: R/L 20/20. Biomicroscopy: red, thickened eyelid margins, crusty debris on rarefied, partially broken lashes, conjunctival telangiectasia, low tear meniscus, further ophthalmologic examination unremarkable. DIAGNOSIS: chronic Demodex blepharoconjunctivitis. THERAPY AND OUTCOME: Conventional treatment was contraindicated due to mercury allergy. Alternative oral minocycline 100 mg daily brought no subjective nor objective relief. Combination of lid scrubs and 2% Metronidazole gel relieved symptoms and halved number of mites after 1 month, lashes grew again after 2 months. Treatment was discontinued after 6 months as Demodex folliculorum proof remained negative. No relapse occurred during 1 year.
CONCLUSIONS: Topical Metronidazole 2% proved to be an effective treatment of chronic Demodex blepharoconjunctivitis in our case and thus may offer a new and save alternative to existing therapies. Neither ocular nor systemic side effects occurred. Controversial theories on the aetiology of blepharitis are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9743939     DOI: 10.1055/s-2008-1034943

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  In vitro and in vivo killing of ocular Demodex by tea tree oil.

Authors:  Y-Y Gao; M A Di Pascuale; W Li; A Baradaran-Rafii; A Elizondo; C-L Kuo; V K Raju; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

Review 2.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

Review 3.  [Treatment options for chronic blepharitis considering current evidence].

Authors:  C Auw-Hädrich; T Reinhard
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

4.  A Clinical Scoring System for Diagnosis of Ocular Demodicosis.

Authors:  Oktay Alver; Sertaç Argun Kıvanç; Berna Akova Budak; Nazmiye Ülkü Tüzemen; Beyza Ener; Ahmet Tuncer Özmen
Journal:  Med Sci Monit       Date:  2017-12-10

5.  Therapeutic effect of intense pulsed light with optimal pulse technology on meibomian gland dysfunction with and without ocular Demodex infestation.

Authors:  Yanan Huo; Yanping Mo; Yaying Wu; Fei Fang; Xiuming Jin
Journal:  Ann Transl Med       Date:  2021-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.